CompletedNCT06037668
A Randomized, Controlled Study of Two At-Home Self-Guided Virtual Reality Interventions for Adults With Social Anxiety Disorder.
Device studyAges 18–99United States
Understand this study
Who was this study for?
This study was for people with anxiety. Listed age limits: 18 years to 99 years. Other eligibility criteria applied.
- Listed locations
- Orlando and 5 more locationsSee all locations and recruitment
Study information
Study start dateStarted: September 8, 2023
- Recruitment status
- Completed
- Enrollment listed in the registry
- 56
- Sponsor
- Sumitomo Pharma America, Inc.
- Sponsor type
- Pharmaceutical company
- Study type
- Device
- Intervention type
- DEVICE
- Study phase
- Not clearly listed
- Locations
- United States
- Age range
- From 18 Years to 99 Years
- Official registry ID
- NCT06037668
- Official title
Show the full official title
BVR-100 and BES-100 Validation Trial: A Randomized, Double-Blind, Parallel-Group, Controlled Study of Two At-Home Self-Guided Virtual Reality Interventions for Adults With Social Anxiety Disorder.
Recruitment & locations
CompletedOrlando · Boston · Saint Charles
2 more locations
- Lincoln
- Draper
Questions about this study
Who is behind this study?
The study sponsor is Sumitomo Pharma America, Inc., a pharmaceutical company.
Who was this study for?
This study was for people with anxiety. Listed age limits: 18 years to 99 years. Other eligibility criteria applied.
Want to find a study that may fit you better?
Answer a few simple questions to explore HopeStage studies by condition, country, and situation.
Find a study that may fit me